Related Experiment Video
Updated: Apr 1, 2026

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
RARβ Promoter Methylation as an Epigenetic Mechanism of Gene Silencing in Non-small Cell Lung Cancer
Abstract:
The retinoid acid receptor-p (RARβ) gene is one of the tumor suppressor genes (TSGs), which is frequently deleted or epigenetically silenced at an early stage of tumor progression. In this study we investigated the promoter methylation and expression status of the RARβ gene in 60 surgically resected non-small cell lung cancer (NSCLC) tissue samples and 60 corresponding unchanged lung tissue samples, using methylation-specific PCR and real-time-polymerase chain reaction (qPCR) techniques. We correlated the results with the pathological features of tumors and clinical characteristics of patients. qPCR analysis detected a significantly lower RARβ expression in the patients with adenocarcinoma (AC) and large cell carcinoma (LCC) than in those with squamous cell carcinoma (SCC) (AC vs. SCC, p = 0.032; AC and LCC vs. SCC, p = 0.0 13). Additionally, significantly lower expression of the RARβ gene was revealed in the patients with non-squamous cell cancer with a history of smoking assessed as pack-years (PY < 40 vs. PY ≥ 40, p = 0.045). Regarding RARβ promoter methylation, we found significant differences in the methylation index in the SCC group when considering pTNM staging; with higher index values in T1a + T1b compared with T2a + T2b and T3 + T4 groups (p = 0.024). There was no correlation between the methylation status and expression level of the RARβ gene, which suggests that other molecular mechanisms influence the RARβ expression in NSCLC patients. In conclusion, different expression of the RARβ gene in SCC and NSCC makes the RARβ gene a valuable diagnostic marker for differentiating the NSCLC subtypes.
Insights
The retinoid acid receptor-beta (RARβ) gene shows different expression levels in non-small cell lung cancer (NSCLC) subtypes. Lower RARβ expression in adenocarcinoma and large cell carcinoma suggests its potential as a diagnostic marker for NSCLC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The retinoid acid receptor-beta (RARβ) gene, a tumor suppressor gene, is often silenced or deleted in early tumor development.
- Investigating RARβ's role in non-small cell lung cancer (NSCLC) is crucial for understanding tumor progression.
Purpose of the Study:
- To analyze the promoter methylation and expression status of the RARβ gene in NSCLC.
- To correlate RARβ status with tumor pathology and patient clinical characteristics.
- To evaluate RARβ as a potential diagnostic marker for NSCLC subtypes.
Main Methods:
- Utilized methylation-specific PCR and real-time quantitative PCR (qPCR) on 60 NSCLC tissues and 60 normal lung tissues.
- Assessed RARβ gene promoter methylation and expression levels.
- Correlated findings with pathological features (e.g., AC, LCC, SCC) and clinical data (e.g., smoking history, pTNM stage).
Main Results:
- Significantly lower RARβ expression was observed in adenocarcinoma (AC) and large cell carcinoma (LCC) compared to squamous cell carcinoma (SCC).
- Reduced RARβ expression was also noted in non-squamous NSCLC patients with a smoking history (≥40 pack-years).
- RARβ promoter methylation showed differences based on pTNM staging in SCC, but no direct correlation with expression levels was found, indicating other regulatory mechanisms.
Conclusions:
- Differential RARβ gene expression distinguishes between NSCLC subtypes (SCC vs. non-SCC).
- The RARβ gene serves as a potential diagnostic marker for differentiating NSCLC subtypes.
- Further research is needed to elucidate other molecular mechanisms regulating RARβ expression in NSCLC.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
MicroRNAs
MicroRNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Experimental RNAi

